Medtronic received information from a literature case report regarding a (b)(6)-year-old morbidly obese male patient with a history of hypertension, paroxysmal atrial fibrillation on warfarin, obstructive sleep apnea, pulmonary embolism, nonischemic cardiomyopathy (left ventricular ejection fraction of 30%) status post resynchronization therapy and implantation of automated internal cardiac defibrillator, aortic aneurysm, and bicuspid aortic valve status following four surgical aortic valve replacement procedures.Due to severe insufficiency and moderate stenosis of the non-medtronic surgical aortic valve, the patient underwent transcatheter aortic valve-in-valve implantation with a medtronic melody transcatheter pulmonary valve (serial number not provided).Afterward, mild-moderate residual paravalvular regurgitation was noted, but the patient's clinical symptoms improved.Four years later, the patient presented with progressive dyspnea and new york heart association class iv heart failure.Transthoracic echocardiography and computed tomography angiography revealed severe valvular and paravalvular aortic incompetence along with a stable ascending aortic aneurysm.The melody valve leaflets were thickened with significant prolapse.The patient was deemed high risk for redo surgery and the decision was made to proceed with transcatheter valve-in-valve-in-valve implantation.Subsequently, a 29 mm medtronic corevalve (serial number not provided) was implanted inside the melody valve.A post-implant balloon aortic valvuloplasty (bav) was performed with a 24 mm non-medtronic balloon.Following the bav, transesophageal fusion imaging and root angiogram showed trivial paravalvular regurgitation.At one-month follow-up, the patient's dyspnea had resolved, and a transthoracic echocardiogram noted trivial paravalvular leak (pvl).Five years after the valve-in-valve-in-valve procedure, the patient was admitted for rapid atrial fibrillation and both transthoracic and transesophageal echocardiography exhibited trivial pvl.No additional adverse patient effects or product performance issues were reported.
|